Position in ACHV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,910,597
New position
Shares Held
6,877,580
first reported quarter
Ownership
6.68%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#2
of 110 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026TPG GP A, LLC holds $564,920,037 across 10 Biotechnology names. ACHV ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SION |
Sionna Therapeutics, Inc.
|
6,494,962 | $285,713,378 | |
| 2 | BCAX |
Bicara Therapeutics Inc.
|
3,010,425 | $89,379,518 | |
| 3 | ODTX |
Odyssey Therapeutics, Inc.
|
3,690,146 | $69,042,631 | |
| 4 | ACHV |
Achieve Life Sciences, Inc.
This page
|
6,877,580 | $44,910,597 | |
| 5 | ALLO |
Allogene Therapeutics, Inc.
|
18,716,306 | $38,929,916 | |
| 6 | AVLN |
Avalyn Pharma Inc.
|
773,069 | $25,449,431 | |
| 7 | RLYB |
Rallybio Corp
|
378,551 | $6,056,816 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
25,000 | $3,318,250 |
All Filings in ACHV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,910,597 | 6,877,580 | Shares | Defined | 2026-08-14 | |
| 2025-04-17 | $27,372,768 | 13,755,160 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||